Metagenomi Inc. (MGX) - Company Gross Revenue

metagenomi.co - graphic logo of issuer MGX

Metagenomi, Inc. (MGX) is building the foundation of future medicine by combining AI and computational libraries to discover gene-editing tools. Gross sales revenue for the company, as shown in the GURU.Markets chart, indicates that the metric value is 0.01. The business relies on a massive array of CRISPR enzymes for DNA therapy, although current earnings are limited solely to research partnerships.

Metagenomi, Inc. (MGX) - Revenue and Sales Volume from 02/21/2024 to 11/17/2026

Comprehensive metric breakdowns and analytics for Metagenomi Therapeutics (MGX)

- stock value and consensus price forecast:
General company analysis:Metagenomi, Inc.
Product sample of Metagenomi, Inc

Metagenomi, Inc. (MGX) is scaling its genome editing developments through strategic alliances with pharmaceutical behemoths. The company's total sales on the GURU.Markets platform capture a daily revenue inflow, reflecting real market demand for innovation. This metric measures operational efficiency and the monetization speed of the pipeline in oncology and genetics. The steady growth of this indicator confirms the viability of the business model and reduces early-stage investment risks.

Analysis of competing companies

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|SGMO (Sangamo Therapeutics) - Company Sales Volume|NAUT: Revenue and Sales Volume|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales